Terns Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1.95 |
1.71 |
1.60 |
6.92 |
32.00 |
26.30 |
| Przychód Δ r/r |
0.00% |
-12.09% |
-6.67% |
332.50% |
362.43% |
-17.81% |
| Przychód (min) |
1.95 |
1.71 |
1.60 |
6.92 |
32.00 |
26.30 |
| Przychód (max) |
1.95 |
1.71 |
1.60 |
6.92 |
32.00 |
26.30 |
| EBITDA (średnia) |
1.17 |
1.03 |
0.96 |
4.15 |
19.20 |
15.78 |
| EBIT (średnia) |
1.17 |
1.03 |
0.96 |
4.15 |
19.20 |
15.78 |
| EBIT % |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-95.80 |
-93.45 |
-86.24 |
-114.95 |
-114.86 |
-73.15 |
| Zysk netto % |
-4913.05% |
-5451.20% |
-5389.94% |
-1661.09% |
-358.95% |
-278.13% |
| EPS (średnia) |
-1.19 |
-1.18 |
-1.21 |
-1.37 |
-1.44 |
-0.92 |
| Liczba analityków (Przychody) |
8 |
6 |
6 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
7 |
6 |
6 |
5 |
2 |
1 |
| symbol |
TERN |
TERN |
TERN |
TERN |
TERN |
TERN |